Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Center, Non-randomized Study to Evaluate the Safety and Efficacy of Left Gastric Artery Embolization, to Promote Short-term Weight Loss in Obese Patients With Nonalcoholic Steatohepatitis (NASH) and Thereby Improve NASH

NCT02933554 is registered in ClinicalTrials.gov with Keith Pereira, MD: as lead sponsor.

NCT NCT02933554
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02933554 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Center, Non-randomized Study to Evaluate the Safety and Efficacy of Left Gastric Artery Embolization, to Promote Short-term Weight Loss in Obese Patients With Nonalcoholic Steatohepatitis (NASH) and Thereby Improve NASH
Lead sponsor
Keith Pereira, MD:
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 31, 2025
Completion date
June 30, 2027
Enrollment
8 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

body weight, nafld, nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, obesity, weight loss